West Pharmaceutical ServicesWST +1.20%95 Interest Coverage is 95.32 as of Mar. 2026, which is 47% above its 10-year median of 64.85. GuruFocus rates WST with a GF Score™ of 95/100 and a GF Value™ of $361.52 (Fairly Valued). The stock has 9 warning signs investors should review. Among 468 Medical Devices & Instruments companies, West Pharmaceutical Services ranks better than 85.9% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. West Pharmaceutical Services's
Operating Income
for the
three
months ended in Mar. 2026 was $181 Mil. West Pharmaceutical Services's Interest Expense for the
three
months ended in Mar. 2026 was $-2 Mil.
West Pharmaceutical Services's interest coverage for the quarter that ended in Mar. 2026 was 95.32.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for West Pharmaceutical Services's Interest Coverage or its related term are showing as below:
WST'
s Interest Coverage Range Over the Past 10 Years
Min: 27.78 Med: 64.85 Max: 1272.2
Current: 344.8
WST's Interest Coverage is ranked better than 85.9% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs WST: 344.80
West Pharmaceutical Services (NYSE:WST) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
West Pharmaceutical Services Interest Coverage Related Terms
West Pharmaceutical Services Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
West Pharmaceutical Services Interest Coverage Chart
WST vs RMD, MDLN, SOLV: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Interest Coverage distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's Interest Coverage falls into.
West Pharmaceutical Services Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services (WST) has a Interest Coverage of 95.32 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on West Pharmaceutical Services and its competitors. This is 47% above median its historical median of 64.85. Over the past decade, West Pharmaceutical Services' Interest Coverage has ranged from 27.78 to 1,272.20. According to the industry distribution chart, West Pharmaceutical Services ranks #66 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 14.1%.
Is West Pharmaceutical Services' Interest Coverage too high?
West Pharmaceutical Services' current Interest Coverage of 95.32 is 47% above median its 10-year median of 64.85. Over the past 10 years, this metric has ranged from a low of 27.78 to a high of 1,272.20. The Medical Devices & Instruments industry median Interest Coverage is 15.71. West Pharmaceutical Services' value of 95.32 is 506.7% above this industry median. Based on the distribution chart, West Pharmaceutical Services ranks #66 out of 468 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, West Pharmaceutical Services has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' Interest Coverage compare to RMD and MDLN?
According to the Medical Devices & Instruments industry distribution chart, West Pharmaceutical Services ranks #66 out of 468 companies for Interest Coverage. This places West Pharmaceutical Services in the top 14% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 15.71. West Pharmaceutical Services' value of 95.32 is 506.7% above this benchmark. Historically, West Pharmaceutical Services' own Interest Coverage has ranged from 27.78 to 1,272.20 over the past decade. While the company's 10-year median is 64.85 vs. the industry median of 15.71, West Pharmaceutical Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. West Pharmaceutical Services's current Interest Coverage of 95.32 is 506.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on West Pharmaceutical Services and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. West Pharmaceutical Services's current Interest Coverage is 95.32, which is 47% above median its own 10-year median of 64.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
Based on GuruFocus' analysis, West Pharmaceutical Services (WST) is currently considered Fairly Valued. The stock's GF Value™ is $361.52, compared to a current price of $340.41 — trading 5.8% below its estimated fair value. The current Interest Coverage is 95.32, which is 47% above median its 10-year median of 64.85 and 506.7% above the Medical Devices & Instruments industry median of 15.71. West Pharmaceutical Services' overall GF Score™ is 95/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For West Pharmaceutical Services (WST), the current Interest Coverage is 95.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is West Pharmaceutical Services (WST) Overvalued in 2026?
Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued.
The current stock price of $340.41 is trading 5.8% below its estimated GF Value™ of $361.52.
GuruFocus considers West Pharmaceutical Services to be Fairly Valued.
Key valuation signals for WST:
Interest Coverage: 95.32 (47% above median its 10-year median of 64.85)
GF Value™: $361.52 vs. price of $340.41 (5.8% below fair value)
Industry Position: 506.7% above the Medical Devices & Instruments median (#66 of 468)
No single metric tells the full story. See the WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
95GF Score
Get the complete analysis for WST
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WST has been successfully added to your 
